Literature DB >> 31285656

Fulfilling the potential of real-world evidence for lung cancer in Canada.

P K Cheema1, S Kuruvilla2.   

Abstract

Entities:  

Year:  2019        PMID： 31285656      PMCID： PMC6588081          DOI： 10.3747/co.26.5151

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  3 in total

1.  Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo).

Authors:  Balazs Halmos; Eng-Huat Tan; Ross A Soo; Jacques Cadranel; Min Ki Lee; Pascal Foucher; Te-Chun Hsia; Maximilian Hochmair; Frank Griesinger; Toyoaki Hida; Edward Kim; Barbara Melosky; Angela Märten; Enric Carcereny
Journal:  Lung Cancer       Date:  2018-11-02       Impact factor: 5.705

2.  Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspective.

Authors:  Keith A Lawson; Olli Saarela; Zhihui Liu; Luke T Lavallée; Rodney H Breau; Lori Wood; Michael A S Jewett; Anil Kapoor; Simon Tanguay; Ronald B Moore; Ricardo Rendon; Frederic Pouliot; Peter C Black; Jun Kawakami; Darrel Drachenberg; Antonio Finelli
Journal:  Can Urol Assoc J       Date:  2017-08       Impact factor: 1.862

3.  Burden of illness for metastatic melanoma in Canada, 2011-2013.

Authors:  D S Ernst; T Petrella; A M Joshua; A Hamou; M Thabane; S Vantyghem; F Gwadry-Sridhar
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677
  3 in total
  2 in total

Review 1.  Innovation in Oncology Drug Development.

Authors:  Matthew Huber; Brian Huber
Journal:  J Oncol       Date:  2019-11-23       Impact factor: 4.375

2.  Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea.

Authors:  Taeyun Kim; Tae Won Jang; Chang Min Choi; Mi-Hyun Kim; Sung Yong Lee; Cheol-Kyu Park; Yoon Soo Chang; Kye Young Lee; Seung Joon Kim; Sei Hoon Yang; Jeong Seon Ryu; Jeong Eun Lee; Shin Yup Lee; Chan Kwon Park; Sang Hoon Lee; Seung Hun Jang; Seong Hoon Yoon
Journal:  Cancer Med       Date:  2021-07-13       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.